Changes in launch delay and availability of pharmaceuticals in 30 European markets over the past two decades

Abstract Background The timing of the launch of a new drug is an important factor that determines access for patients. We evaluated patient access to pharmaceuticals in 30 European markets over the past two decades. Methods Launch dates were extracted from the IQVIA (formerly IMS) database for 30 Eu...

Full description

Bibliographic Details
Main Authors: Melanie Büssgen, Tom Stargardt
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Health Services Research
Subjects:
Online Access:https://doi.org/10.1186/s12913-022-08866-7